Stay updated with breaking news from Nasdaq Beam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ARK Investment Management LLC raised its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 4.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,783,891 shares of the company’s stock after acquiring an additional 401,296 shares during the […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $28.75, but opened at $27.49. Beam Therapeutics shares last traded at $27.45, with a volume of 241,061 shares. Wall Street Analyst Weigh In BEAM has been the subject of several recent analyst […]
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have received a consensus recommendation of “Hold” from the eleven ratings firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average rating of “Hold” from the eleven analysts that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target […]
Wedbush reissued their outperform rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a research note released on Monday morning, RTT News reports. They currently have a $48.00 target price on the stock. Wedbush also issued estimates for Beam Therapeutics’ FY2024 earnings at ($4.32) EPS, FY2025 earnings at ($4.65) EPS, FY2026 earnings at […]